tumor mutational burden Jul 21, 2020 NCCN's Updated Inherited Colorectal Cancer Risk Guidelines Features Gene-Specific Information Jun 17, 2020 FDA Approves Merck's Keytruda, Foundation Medicine CDx for TMB-High Solid Tumors Apr 14, 2020 Merck Bid for Second Pan-Cancer Keytruda Indication Would Raise Tumor Mutation Burden to CDx Status Feb 12, 2020 Exact Sciences Boosting Position in Cancer Dx Market Through M&A Premium Dec 17, 2019 NeoGenomics Focused on Companion Diagnostics, NGS in 2020 Premium Nov 19, 2019 Despite FDA Clearance for NantHealth Test, Benefits of TMB Biomarker Unclear Premium Nov 12, 2019 AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions Premium Sep 23, 2019 PGDx Shares New MSI Data, Provides Update on FDA Bid for Pan-Cancer IVDs Premium Aug 8, 2019 NantHealth Q2 Revenues Grow 17 Percent Jan 15, 2019 Tumor Mutation Burden Predicts Immunotherapy Benefit Across Cancers, Though Cutoffs Differ Premium Jan 11, 2019 Foundation Medicine Says Tumor Mutational Burden Reporting Issue on CDx Test Is Resolved Jan 7, 2019 PGDx, PathGroup to Co-Develop Genomic Profiling Assay Jan 3, 2019 PGDx Inks Agreements With KingMed, Merck for Tissue-Based TMB Testing Aug 6, 2018 Study Describes Design, Validation of Foundation Medicine's Blood-Based TMB Test Jul 31, 2018 Guardant Silent on TMB Plans as Study Adds Evidence for Immunotherapy Prediction in Blood Premium Apr 30, 2018 With Promising Data in Early-Stage NSCLC, PGDx Continues TMB Test Kit Development Premium Breaking News Elevated Antibody Levels Identified in Patients With Severe Chronic Fatigue Syndrome In Brief This Week: Exact Sciences, Hologic, T2 Biosystems, Agilent, More Biosynex Files Takeover Bid to Buy Theradiag Congress to Pass FDA User Fee Bill Without VALID Act, Again Putting Aside LDT Regulation Bionano Genomics Launches CLIA-Certified Laboratory, First OGM-Based Test Caris Life Sciences to Offer Molecular Profiling Services on Flatiron Health Platform
